When the IBM PC was new, I served as the president of the San Francisco PC User Group for three years. That’s how I met PCMag’s editorial team, who brought me on board in 1986. In the years since that ...
Scouring through corporate communications and broker research isn’t enough Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The ...
Cloud-native Ateliere Storyline automatically reformats long-form video into vertical, serialized content at scaleLOS ANGELES, June 09, 2026 (GLOBE NEWSWIRE) -- Ateliere Creative Technologies, a ...
(MENAFN- GlobeNewsWire - Nasdaq) Cloud-native Ateliere Storyline automatically reformats long-form video into vertical, serialized content at scale LOS ANGELES, June 09, 2026 (GLOBE NEWSWIRE) -- ...
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...
LOS ANGELES, June 09, 2026 (GLOBE NEWSWIRE) -- Ateliere Creative Technologies, a leading cloud-native video supply chain software company, today announced Ateliere Storyline, a new automated content ...
Ateliere Connect enables content owners with large video libraries to automatically reformat existing long-form assets for vertical viewing. The functionality also identifies natural breakpoints and ...
Trials of the British Army’s Ajax armoured vehicles are set to resume, despite major delays amid concern for soldiers’ safety. Minister for Defence Readiness and Industry Luke Pollard announced in ...
LONDON, April 28 (Reuters) - Britain's defence readiness minister Luke Pollard said he had agreed to restart the army's acceptance of Ajax armoured vehicles from General Dynamics with strict controls ...
Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to expand its oncology pipeline. Lilly has been ...
Eli Lilly’s run of near-weekly acquisitions still shows no sign of letting up, with the Big Pharma now buying Ajax Therapeutics for its clinical-stage myelofibrosis therapy. At the center of the deal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results